NCT07069309 · Interventional trial
A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years
Overall registry status Completed
Phase 3
Conditions COVID-19, SARS-COV-2 Infection
Delaware Valley sites
- DM Clinical Research - Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory